Shares of CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $14.60 and traded as high as $17.14. CryoPort shares last traded at $16.84, with a volume of 706,377 shares traded.
Wall Street Analyst Weigh In
Several research analysts have issued reports on CYRX shares. Guggenheim upped their price objective on CryoPort from $16.00 to $19.00 and gave the stock a "buy" rating in a report on Thursday, October 1st. Robert W. Baird set a $26.00 price objective on CryoPort in a research report on Tuesday. Weiss Ratings upgraded CryoPort from a "sell (d)" rating to a "hold (c-)" rating in a research report on Thursday, October 8th. Roth Capital reissued a "buy" rating and issued a $21.00 target price on shares of CryoPort in a research note on Friday, August 7th. Finally, BTIG Research lifted their target price on CryoPort from $25.00 to $26.00 and gave the company a "buy" rating in a research note on Tuesday. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, CryoPort currently has an average rating of "Moderate Buy" and a consensus target price of $19.33.
Read Our Latest Report on CryoPort
CryoPort Trading Down 1.3%
The stock has a market capitalization of $852.95 million, a P/E ratio of -18.71 and a beta of 1.96. The company has a fifty day simple moving average of $16.46 and a two-hundred day simple moving average of $14.60.
CryoPort (NASDAQ:CYRX - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.01). The business had revenue of $48.97 million for the quarter, compared to analyst estimates of $48.18 million. CryoPort had a negative net margin of 20.05% and a negative return on equity of 7.20%. As a group, analysts forecast that CryoPort, Inc. will post -0.83 earnings per share for the current fiscal year.
Insider Buying and Selling at CryoPort
In related news, CEO Jerrell Shelton sold 28,800 shares of the business's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $14.91, for a total transaction of $429,408.00. Following the completion of the sale, the chief executive officer directly owned 1,201,814 shares of the company's stock, valued at $17,919,046.74. The trade was a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 9.50% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On CryoPort
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. State of Alaska Department of Revenue acquired a new stake in CryoPort during the 3rd quarter worth $40,000. Highland Investment Advisors LLC acquired a new position in shares of CryoPort in the 2nd quarter valued at $306,000. Kerrisdale Advisers LLC bought a new position in shares of CryoPort in the 2nd quarter worth $355,000. Engineers Gate Manager LP bought a new position in shares of CryoPort in the 2nd quarter worth $518,000. Finally, Headlands Technologies LLC boosted its position in shares of CryoPort by 14.5% in the 2nd quarter. Headlands Technologies LLC now owns 38,742 shares of the company's stock worth $608,000 after purchasing an additional 4,906 shares during the last quarter. 92.90% of the stock is owned by institutional investors.
About CryoPort
(
Get Free Report)
CryoPort, Inc is a life sciences logistics company that provides temperature-controlled supply chain solutions for the development, manufacture and delivery of advanced therapies, biologics and other temperature-sensitive materials. Its services are used in areas including cell and gene therapy, regenerative medicine, pharmaceuticals, clinical research and reproductive medicine.
The company offers specialized shipping systems, cryogenic storage and monitoring technologies, logistics coordination, inventory management and related support services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CryoPort, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CryoPort wasn't on the list.
While CryoPort currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
